HUBUNGAN BERAT BADAN TERHADAP ENHANCEMENT HEPAR PADA PEMERIKSAAN CT SCAN ABDOMEN 3 FASE PADA PASIEN DENGAN KLINIS HEPATOCELLULAR CARCINOMA

THE CORRELATION BETWEEN BODY WEIGHT AND HEPATIC ENHANCEMENT IN THREE-PHASE ABDOMINAL CT SCAN EXAMINATIONS WITH CLINICAL HEPATOCELLULAR CARCINOMA

Authors

  • Mahfud Edy Widiatmoko Poltekkes Kemenkes Jakarta II

DOI:

https://doi.org/10.38215/jtkes.v8i2.220

Keywords:

Arterial Phase, Body Weight, CT abdomen 3 Phases, Hepar Enhancement, Venous Phase

Abstract

Enhancement of the liver on CT Scan of the abdomen, 3 phases. Influenced by various factors, one of which is body weight. Body weight shows an inverse relationship of one-to-one with contrast enhancement. Body weight shows an inverse relationship of one-to-one with contrast enhancement. Body weight affects the level of enhancement in the vascular and parenchymal areas. Contrast media that is more dilute when administered to patients with larger blood volumes and higher body weights compared to thinner patients. This results in reduced contrast concentration in the blood and lower contrast enhancement. This study aims to analyze the relationship between body weight and liver enhancement in 3-phase abdominal CT scans with clinical hepatocellular carcinoma. The study design is an analytical quantitative study using Pearson's correlation test on the average HU values of the liver from three body weight groups. The study was conducted at Persahabatan Hospital from January to May 2024 with 30 samples using purposive sampling. The results showed that the hepatic enhancement value with p-value 0.000 and r-value -0.612 for arterial phase and p-value 0.000 and r-value -0.629 for the venous phase. Conclusion: Body weight is inversely related to hepatic enhancement

Downloads

Download data is not yet available.

References

Adibi, A., & Shahbazi, A. (2014). Automatic bolus tracking versus fixed time-delay technique in biphasic multidetector computed tomography of the abdomen. Iranian Journal of Radiology, 11(1), 1–5. https://doi.org/10.5812/iranjradiol.4617

Bae, K. T. (2010). Intravenous contrast medium administration and scan timing at CT: Considerations and approaches. Radiology, 256(1), 32–61. https://doi.org/10.1148/radiol.10090908

de Jong, D. J., Veldhuis, W. B., Wessels, F. J., de Vos, B., Moeskops, P., & Kok, M. (2021). Towards personalised contrast injection: Artificial-intelligence-derived body composition and liver enhancement in computed tomography. Journal of Personalized Medicine. https://doi.org/10.3390/jpm11030159

Feng, S. T., Zhu, H., Peng, Z., Huang, L., Dong, Z., Xu, L., Huang, K., Yang, X., Lin, Z., & Li, Z. P. (2017). An individually optimized protocol of contrast medium injection in enhanced CT scan for liver imaging. Contrast Media & Molecular Imaging. https://doi.org/10.1155/2017/7350429

Jensen, C. T., Blair, K. J., Wagner-Bartak, N. A., Vu, L. N., Carter, B. W., Sun, J., Bathala, T. K., & Gupta, S. (2019). Comparison of Abdominal Computed Tomographic Enhancement and Organ Lesion Depiction between Weight-Based Scanner Software Contrast Dosing and a Fixed-Dose Protocol in a Tertiary Care Oncologic Center. Journal of Computer Assisted Tomography, 43. https://doi.org/10.1097/RCT.0000000000000789

Kim, M., Kang, T. W., Cha, D. I., Jang, K. M., Kim, Y. K., Kim, S. H., Sinn, D. H., & Kim, K. (2019). Identification of arterial hyperenhancement in CT and mri in patients with hepatocellular carcinoma: Value of unenhanced images. Korean Journal of Radiology, 20(2), 236–245. https://doi.org/10.3348/kjr.2018.0339

Legesse, T. K., Getaneh, M. M., & Issa, S. A. (2023). Evaluation of the Practice of Performing Abdominal CT Scan with Manually Administered Fixed Dose of Contrast in Achieving Adequate Hepatic Enhancement: An Institutional-Based Cross-Sectional Study. Radiology Research and Practice, 2023(1), 1–8. https://doi.org/10.1155/2023/9563310

McGlynn, K. A., Petrick, J. L., & El-Serag, H. B. (2021). Epidemiology of Hepatocellular Carcinoma. Hepatology, 73(S1), 4–13. https://doi.org/10.1002/hep.31288

Nadarevic, T., Colli, A., Giljaca, V., Fraquelli, M., Casazza, G., Manzotti, C., Štimac, D., & Miletic, D. (2022). carcinoma in adults with chronic liver disease. Cochrane Library. https://doi.org/10.1002/14651858.CD013362.pub2.www.cochranelibrary.com

Paulo, G., Damilakis, J., Tsapaki, V., Schegerer, A. A., Repussard, J., Jaschke, W., Frija, G., Hierath, M., & Clark, J. (2020). Diagnostic Reference Levels based on clinical indications in computed tomography: a literature review. Insights into Imaging, 11(1). https://doi.org/10.1186/s13244-020-00899-y

Romans, L. E. (2011). Computed Tomography for Technologists : A Comprehensive Text.

Yang, J. D., & Heimbach, J. K. (2020). New advances in the diagnosis and management of hepatocellular carcinoma. The BMJ, 371. https://doi.org/10.1136/bmj.m3544

Published

08/01/2025

How to Cite

HUBUNGAN BERAT BADAN TERHADAP ENHANCEMENT HEPAR PADA PEMERIKSAAN CT SCAN ABDOMEN 3 FASE PADA PASIEN DENGAN KLINIS HEPATOCELLULAR CARCINOMA: THE CORRELATION BETWEEN BODY WEIGHT AND HEPATIC ENHANCEMENT IN THREE-PHASE ABDOMINAL CT SCAN EXAMINATIONS WITH CLINICAL HEPATOCELLULAR CARCINOMA. (2025). Jurnal Teras Kesehatan, 8(2), 46-54. https://doi.org/10.38215/jtkes.v8i2.220

Similar Articles

1-10 of 20

You may also start an advanced similarity search for this article.